The Health 202: Industry is tussling over drug prices. But it's united on combating Medicare-for-all
The big industry players are simultaneously allies and enemies.
Related articles
-
Hong Kong democrats hope to regain veto powers in crucial by-election
November 25, 2018 -
Financial fruit: Apple becomes 1st trillion-dollar company
August 2, 2018 -
‘Never give an inch’: Trump keeps touting perceived failures as successes
September 13, 2018
